Regenerative Medicine: Advanced Therapy for Muscle Tissue Restoration.

Area of Science:

• Biomedical Science
• Regenerative Medicine
• Muscle Biology

Background:

• Skeletal muscle loss due to injury, sarcopenia, and myopathies presents significant clinical challenges.
• Adult muscle tissue has limited regenerative capacity, necessitating advanced therapeutic interventions.

Purpose of the Study:

• To systematically review advanced biomedical therapeutic strategies for restoring muscle mass and function.
• To discuss key mechanisms of muscle regeneration and the challenges in clinical translation.

Main Methods:

• Systematic review of literature on gene therapy, microRNA, cell-based strategies, and tissue engineering for muscle regeneration.
• Analysis of preclinical and clinical studies on myogenic factors, growth factors (IGF-1, VEGF), and transcriptional regulators.
• Examination of emerging combinatorial approaches including rehabilitation, immunomodulation, and exosome therapy.

Main Results:

• Preclinical studies show viral/non-viral delivery of myogenic factors can improve muscle repair and function.
• Clinical trials for sarcopenia and muscle defects show modest gains but no definitive regenerative therapy is approved.
• Challenges include immune responses, reinnervation issues, and replicating native tissue architecture.

Conclusions:

• Advanced biomedical strategies show potential for muscle regeneration, but clinical translation remains complex.
• Combinatorial approaches addressing vascularization, innervation, and the microenvironment are crucial for full muscle regeneration.
• Further research is needed to overcome clinical hurdles and develop effective regenerative therapies for muscle loss.